Goodnites Wart Removal Gel

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be cleaned thoroughly prior to application. A thin layer of the product should be applied to the skin tag using the provided applicator. It is essential to allow the application to dry completely. The application should be repeated twice daily for a duration of up to 4 weeks, or as directed by a healthcare professional.

Contraindications

Use of this product is contraindicated in the following situations:

Application is not recommended on irritated, infected, or reddened skin, as well as on genital warts or warts located on the face. Additionally, individuals with diabetes or poor blood circulation should not use this product due to the potential for adverse effects.

The product should not be applied near the eyes or mucous membranes to prevent irritation or injury.

If the condition worsens, excessive irritation develops, or unexpected side effects occur, discontinue use immediately.

Warnings and Precautions

This product is intended for external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

It is contraindicated to apply this product on irritated, infected, or reddened skin. Additionally, it should not be used on genital warts or warts located on the face. Patients with diabetes or those who have poor blood circulation should refrain from using this product due to potential complications.

Users are advised to discontinue use if the condition being treated worsens or if excessive irritation develops. Should unexpected side effects occur, it is imperative to stop use and consult a healthcare professional.

Care should be taken to avoid contact with the eyes and mucous membranes, as this may lead to adverse reactions. While mild irritation may be a common occurrence, any excessive irritation warrants immediate cessation of use and consultation with a physician.

Side Effects

Patients should be aware that the product is intended for external use only. In clinical practice, it is important to monitor for any adverse reactions that may arise during treatment.

Common adverse reactions reported include worsening of the condition being treated, excessive irritation at the application site, and the occurrence of unexpected side effects. If any of these reactions are observed, it is advised that patients discontinue use of the product and consult a healthcare professional for further guidance.

Healthcare providers should remain vigilant for these potential adverse reactions to ensure patient safety and effective management of any side effects that may occur.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Goodnites Wart Removal Gel (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients may use this medication for external application on irritated, infected, or reddened skin. It is important to avoid application on genital warts or warts located on the face. The medication should not be used in children with diabetes or poor blood circulation, and care should be taken to avoid contact with the eyes or mucous membranes.

Prior to application, the affected area should be cleaned thoroughly. A thin layer of the medication should be applied to the skin tag using the provided applicator, ensuring that it dries completely. The recommended dosing is twice daily for up to 4 weeks, or as directed by a healthcare professional.

Mild irritation may occur; however, if excessive irritation develops, or if the condition worsens or unexpected side effects arise, medical assistance should be sought promptly.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of Goodnites Wart Removal Gel in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for use during pregnancy. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks versus benefits of treatment in this population. It is recommended that pregnant patients consult their healthcare provider for personalized guidance.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for Goodnites Wart Removal Gel. Therefore, the effects on breastfed infants and the excretion of the drug in human milk remain unknown. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

Healthcare professionals should also consider contacting a poison control center for guidance on specific interventions and antidotes that may be appropriate based on the clinical scenario. Continuous monitoring and supportive measures should be implemented until the patient is stabilized and any potential complications are addressed.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and any symptoms observed, is crucial for ongoing management and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified instances of mild irritation associated with the use of the product. In some cases, users have reported that their condition worsened following application. Additionally, occurrences of excessive irritation have been noted, prompting recommendations to discontinue use and consult a healthcare professional if such symptoms arise. Reports also indicate that some individuals experienced unexpected side effects.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a thin layer applied to the skin tag using the provided applicator. It is essential to allow the application to dry fully. Patients should repeat this application twice daily for up to four weeks or as directed by a healthcare professional.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Goodnites Wart Removal Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)